Bulk Kava Extract Supplier | 30% Kavalactones HPLC, 70% Fat-Soluble & Water-Soluble Grades, B2B Wholesale
Valeherb supplies kava extract (Piper methysticum) in three B2B grades: 30% kavalactones by HPLC (water-alcohol extraction, Noble variety, Fiji-imported raw material); 70% fat-soluble kavalactone oleoresin; and water-soluble kavalactone grades at 5,000–12,000 ppm. All grades are standardized by HPLC — not UV — with individual breakdown of all six kavalactones per COA. Kava is one of the most frequently adulterated botanical extracts in the B2B market; the quality controls described on this page are the minimum a responsible buyer should require before committing to volume.
Active Compounds: Six Kavalactones and Why Chemotype Matters
Six major kavalactones account for approximately 96% of the total kavalactone content of Piper methysticum root. Their relative ratio — the chemotype — varies by cultivar and determines the material’s functional profile. Valeherb’s 30% HPLC grade COA (Batch ZDK260909, 1,200 kg) shows the following individual kavalactone breakdown:
| Kavalactone | Batch Result (ZDK260909) | Mechanism Studied in Research | Notes |
|---|---|---|---|
| Kavain (Kawain) | 9.61% | GABA-A receptor modulation; voltage-gated Na⁺/Ca²⁺ channel modulation | Most abundant kavalactone in Noble varieties; studied for anxiolytic activity; kavain dominance is the hallmark of a genuine Noble chemotype |
| Dihydrokavain (DHK) | 7.96% | GABA-A receptor modulation | Studied for sedative and muscle-relaxant activity; elevated in nighttime formulations |
| Yangonin | 4.39% | CB1 receptor partial agonist; GABA-A modulation | Studied for mood-modulating activity |
| Desmethoxyyangonin (DMY) | 3.49% | MAO-B inhibition; dopamine reuptake inhibition | Studied for mood-related activity |
| Methysticin | 2.60% | MAO-B inhibition; GABA-A modulation | Studied for GABAergic and neuroprotective activity |
| Dihydromethysticin (DHM) | 2.43% | GABA-A modulation; COX inhibition | Studied for analgesic and inflammatory-pathway activity; elevated DHM is a marker for tudei contamination risk |
| Total Kavalactones | 30.48% | — | HPLC method; specification ≥30% |
Why HPLC — Not UV — Is the Only Acceptable Test Method
UV spectrophotometry measures total absorbance at a fixed wavelength and cannot distinguish between individual kavalactones or between kavalactones and co-extracted interfering compounds. In practice, UV-tested kava extract will report a higher apparent kavalactone percentage than HPLC on the same material — because UV cannot exclude chromophoric impurities and resin co-extractives that absorb at the same wavelength.
Extraction Method: Water-Alcohol vs. CO₂ Supercritical — Which to Specify
The extraction solvent used to produce kava extract significantly affects the composition, colour, water-dispersibility, and downstream formulation behaviour of the material. Two methods dominate commercial supply:
| Parameter | Water-Alcohol Extraction | CO₂ Supercritical Extraction |
|---|---|---|
| Colour | Dark brown to brown — from co-extracted polyphenols, chlorophylls, and tannins | Lemon yellow to pale amber — clean, resin-dominant extract with minimal co-pigmentation |
| Kavalactone profile | Full-spectrum including polar minor compounds; consistent with traditional aqueous kava preparation | Selectively concentrated in lipophilic kavalactones (kavain, yangonin, desmethoxyyangonin); polar co-extractives largely excluded |
| Water dispersibility | Limited — requires emulsifier or carrier for aqueous formulations | Very low — oleoresin/fat-soluble fraction; designed for lipid-based formats (softgels, oil-based tinctures) |
| Residual solvent | Residual ethanol — confirm within regulatory limits per target market (ICH Q3C) | None — CO₂ is inert and leaves no residue at ambient conditions |
| Finished product colour impact | Significant — darkens capsule fill; requires opacity management in clear softgels or beverages | Minimal — light colour suitable for colour-sensitive formulations |
| Typical application | Standard capsules, tinctures, functional beverages (where colour is acceptable); the 30% HPLC grade | High-potency softgels, precision-dose lipid formulations; the 70% fat-soluble oleoresin grade |
| Valeherb recommendation | Suitable for most applications; specify when traditional full-spectrum profile is required | Preferred for premium formulations — no residual solvent, clean colour, higher kavalactone concentration, superior stability in lipid matrices |
Available Grades and Specifications
30% Kavalactones — Water-Alcohol Extraction (Noble Variety, Fiji)
- ≥30% total kavalactones by HPLC; individual six-kavalactone breakdown on every COA (see table above)
- Noble variety, root only; raw material imported directly from Fiji with origin certificate
- Dark brown colour characteristic of water-alcohol extraction
- Heavy metals, microbial, moisture, and ash tested per batch; full COA on request
70% Kavalactones — CO₂ Supercritical Extraction (Fat-Soluble Oleoresin)
- 70% total kavalactones by HPLC, lipophilic fraction concentrated by supercritical CO₂
- Lemon-yellow colour; no residual solvent
- Designed for softgel, oil-based tincture, and lipid-matrix formulations
- Individual six-kavalactone breakdown available on COA
- Contact Valeherb for current batch COA and sample
Water-Soluble Grade — 5,000–12,000 ppm
- Water-dispersible kavalactone preparation for beverage, kava bar, and ready-to-mix applications
- 5,000–12,000 ppm total kavalactones by HPLC (ppm = mg/kg)
- Individual six-kavalactone breakdown provided per batch — do not accept this grade without HPLC-confirmed individual breakdown
- This grade carries the highest adulteration risk in the kava market; Valeherb applies the same HPLC verification protocol as solid extract grades
- Functional beverage and kava bar segment is currently the largest end-use market for this grade
Published Research
GABAergic and Anxiety Research
A Cochrane systematic review by Pittler & Ernst (2003) pooled randomized, double-blind, placebo-controlled trials and reported that standardized kava extract was associated with statistically significant reductions in Hamilton Anxiety Rating Scale (HAM-A) scores versus placebo, with an adverse-event profile comparable to placebo at the doses studied.[2]
Sarris et al. (2020) ran a 16-week, multi-site, double-blind, placebo-controlled Phase III trial in 171 participants with diagnosed generalized anxiety disorder (GAD), using an aqueous Noble kava extract standardized to 120 mg kavalactones twice daily. Kava was well tolerated but did not separate from placebo on the primary HAM-A endpoint.[3] A neuroimaging sub-study (Savage et al., 2023) reported a significant reduction in dorsal anterior cingulate cortex GABA at eight weeks in the kava group (p = 0.049).[1]
Sleep Research
Lehrl (2004) studied a standardized kava extract (200 mg/day, 4 weeks) in participants with sleep disturbances associated with non-psychotic anxiety and reported improvements on sleep-quality questionnaire sub-scores versus placebo.[4]
Application Categories
- Functional beverages and kava bars — currently the largest end-use segment for bulk kava. Water-soluble grade (5,000–12,000 ppm) is specified for direct aqueous dispersion. Traditional Pacific aqueous kava preparation informs beverage positioning; HPLC verification is essential given high adulteration risk in this segment
- Stress-support and relaxation supplements — 30% HPLC grade in capsule formats. Often combined with ashwagandha, L-theanine, and passionflower in adaptogen-based relaxation formulations
- Nighttime and sleep-support formulas — dihydrokavain-enriched chemotypes selected for these formats; lower-dose kava combined with melatonin, valerian, or magnesium glycinate
- High-potency softgels and precision-dose lipid formulations — 70% fat-soluble CO₂ oleoresin; no residual solvent; lemon-yellow colour; superior stability in lipid matrices
- Tinctures and liquid drops — alcohol or glycerin extraction; specify kavalactone mg/mL on COA for label declaration
Sourcing Criteria
| Criterion | What to Require |
|---|---|
| Test method | HPLC only — UV cannot distinguish kavalactones from interfering co-extractives and consistently over-reports total kavalactone content. Reject any COA that does not specify HPLC as the analytical method |
| Individual kavalactone breakdown | All six kavalactones (kavain, DHK, yangonin, DMY, methysticin, DHM) must be listed separately on COA. Total percentage without individual breakdown is insufficient for cultivar verification or chemotype confirmation |
| Cultivar documentation | Noble variety certificate — not just “Piper methysticum.” Kavain content relative to DHM on the COA is the analytical confirmation of Noble chemotype (kavain should be the dominant single kavalactone) |
| Plant part | Root and rhizome only — aerial parts have a different kavalactone profile and have been associated in the literature with higher hepatotoxicity risk |
| Origin | Fiji, Vanuatu, or Tonga — primary sources of documented Noble varieties. Request origin certificate |
| Safety panel | Heavy metals (USP <232>), pesticide residues, microbial limits (USP <2021>), pipermethystine testing recommended (tudei alkaloid marker) |
Regulatory Background — Read Carefully Before Sourcing
- United States (DSHEA): Legal dietary supplement ingredient. FDA issued a consumer advisory in 2002 regarding rare liver-injury reports — a liver-health label warning is standard practice.[5] Relaxation-type structure/function claims are more defensible; anxiety-related wording is disease-adjacent and carries higher regulatory scrutiny
- European Union: Status varies by member state. Germany banned kava in 2002 (ban lifted 2015); regulatory environment remains cautious. France and UK have restrictions. Confirm in each target market before procurement
- Canada: Liver health cautionary statement required. NHP licence required; monograph available with restricted dosing guidance
- Australia: Regulated under TGA oversight with controls on quantities and therapeutic claims
- Beverage applications: Kava bars and functional kava beverages operate under a separate regulatory framework in most markets. Confirm applicable food/beverage regulations in addition to supplement regulations for this end-use
